Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Patient agency in contraceptive decision-making is an essential component of reproductive autonomy.

Objective: We aimed to develop a psychometrically robust measure of patient contraceptive agency in the clinic visit, as a measure does not yet exist.

Design: For scale development, we generated and field tested 54 questionnaire items, grounded in qualitative research. We used item response theory-based methods to select and evaluate scale items for psychometric performance. We iteratively examined model fit, dimensionality, internal consistency, internal structure validity, and differential item functioning to arrive at a final scale.

Participants: A racially/ethnically diverse sample of 338 individuals, aged 15-34 years, receiving contraceptive care across nine California clinics in 2019-2020.

Main Measures: Contraceptive Agency Scale (CAS) of patient agency in preventive care.

Key Results: Participants were 20.5 mean years, with 36% identifying as Latinx, 26% White, 20% Black, 10% Asian/Native Hawaiian/Pacific Islander. Scale items covered the domains of freedom from coercion, non-judgmental care, and active decision-making, and loaded on to a single factor, with a Cronbach's α of 0.80. Item responses fit a unidimensional partial credit item response model (weighted mean square statistic within 0.75-1.33 for each item), met criteria for internal structure validity, and showed no meaningful differential item functioning. Most participants expressed high agency in their contraceptive visit (mean score 9.6 out of 14). One-fifth, however, experienced low agency or coercion, with the provider wanting them to use a specific method or to make decisions for them. Agency scores were lowest among Asian/Native Hawaiian/Pacific Islander participants (adjusted coefficient: -1.5 [-2.9, -0.1] vs. White) and among those whose mothers had less than a high school education (adjusted coefficient; -2.1 [-3.3, -0.8] vs. college degree or more).

Conclusions: The Contraceptive Agency Scale can be used in research and clinical care to reinforce non-coercive service provision as a standard of care.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160288PMC
http://dx.doi.org/10.1007/s11606-022-07774-0DOI Listing

Publication Analysis

Top Keywords

agency contraceptive
12
contraceptive agency
12
agency
9
contraceptive decision-making
8
patient agency
8
item response
8
scale items
8
internal structure
8
structure validity
8
differential item
8

Similar Publications

Sexual health behavior trends in a nationally representative sample of Canadian migrant adolescents from 2014 to 2022.

BMC Public Health

September 2025

Stigma and Resilience Among Vulnerable Youth Centre, The University of British Columbia, University of British Columbia School of Nursing, T201-2211 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada.

Background: Migrant youth in Canada are disproportionately vulnerable to the consequences of inadequate contraception use compared to their Canada-born peers, yet the sexual health behaviours of this population across time are poorly understood. This study mapped national Canadian trends in migrant adolescent sexual health behaviors disaggregated by migrant status and sex over eight years.

Methods: Canadian Health Behaviour in School-aged Children (HBSC) study data were analyzed in 2014, 2018, and 2022 for sexual experience, condom, contraceptive pill, dual and neither method use at last intercourse.

View Article and Find Full Text PDF

Background: Despite progress in various aspects of women's rights and health, a significant gap persists in the area of reproductive health decisions among women in Sub-Saharan Africa. This study seeks to address this gap by investigating the interplay between educational access, economic autonomy, and digital systems on the sexual and reproductive health (SRH) outcomes of married women in the Sub-Saharan African context.

Methods: Leveraging cross-sectional data obtained from the latest demographic and health surveys conducted across 16 Sub-Saharan African nations between January 2015 and December 2021, the study's focus centred on 67,437 married women.

View Article and Find Full Text PDF

Aprocitentan: a new horizon in the treatment of hypertension.

Expert Opin Pharmacother

August 2025

Department of Medicine, McGill University, Quebec, Canada.

Introduction: There has been a lack of novel medication classes approved for reducing blood pressure (BP) in hypertensive patients. Endothelins, powerful vasoconstricting peptides, have been at the forefront of experimental hypertension research since they were discovered in 1988. The recent PRECISION trial demonstrated the efficacy of aprocitentan, a novel endothelin receptor antagonist, in lowering blood pressure in patients with resistant hypertension (RH).

View Article and Find Full Text PDF

Pathways to Adolescent Pregnancy in Southeast Asia: Qualitative Evidence From Lived Experiences of Girls in Four Countries.

J Adolesc Health

August 2025

Global Adolescent Health, Women's, Children's and Adolescents' Health Program, Burnet Institute, Melbourne, Victoria, Australia; Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Carlton, Victoria, Australia.

Purpose: Historically, adolescent pregnancy has been conceptualized as an outcome of child marriage, but in Southeast Asia, the contexts and drivers of adolescent pregnancy are less well-understood. This study examines the relationship between adolescent pregnancy and child marriage and explores the drivers of pregnancy in Cambodia, Indonesia, Lao People's Democratic Republic and Malaysia among adolescents who have experienced pregnancy.

Methods: Using participatory timeline interviews, we conducted semistructured interviews with 260 adolescent girls aged 15-21 years with lived experience of pregnancy in urban and rural settings in Cambodia, Indonesia, Lao People's Democratic Republic and Malaysia.

View Article and Find Full Text PDF

The "intention to use" (ITU) contraception indicator has gained recent prominence as a proposed high-level success metric for family planning (FP) programs and as a step toward identifying measures that better capture what women want. Although ITU offers advantages over traditional indicators like contraceptive prevalence and unmet need, its elevation as a key programmatic measure requires critical examination. In this commentary, we outline advantages of ITU to measure FP demand and offer critiques and considerations for reliance on ITU as a demand metric for measuring programmatic success.

View Article and Find Full Text PDF